BlueMeme
4069
Renascience
4889
Tecnisco
2962
Twenty-four seven
7074
Hisamitsu Pharmaceutical
4530
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 25.70%4.1B | 113.98%3.26B | -44.34%1.52B | -13.19%2.74B | 37.31%3.15B | -63.49%2.3B | 392.25%6.29B | -39.52%1.28B | -12.83%2.11B | -28.18%2.42B |
Net profit before non-cash adjustment | 17.90%3.39B | 19.87%2.87B | 7.64%2.4B | -7.21%2.23B | -9.37%2.4B | 5.04%2.65B | 36.24%2.52B | 14.77%1.85B | -32.79%1.61B | -3.31%2.4B |
Total adjustment of non-cash items | -3.95%925M | 1,167.11%963M | -63.46%76M | -56.03%208M | 28.88%473M | -56.41%367M | 4.34%842M | -15.94%807M | 934.78%960M | -109.57%-115M |
-Depreciation and amortization | 4.03%619M | -0.83%595M | 1.52%600M | 1.90%591M | 16.23%580M | -10.73%499M | -4.93%559M | 2.62%588M | 21.66%573M | -1.46%471M |
-Reversal of impairment losses recognized in profit and loss | --70M | --0 | -37.50%5M | --8M | ---- | -61.19%26M | 103.03%67M | --33M | ---- | ---- |
-Share of associates | 13.79%-25M | 27.50%-29M | -185.71%-40M | -180.00%-14M | 81.48%-5M | -17.39%-27M | 4.17%-23M | -50.00%-24M | -23.08%-16M | 35.00%-13M |
-Disposal profit | -1,975.00%-375M | 2,100.00%20M | 99.67%-1M | -1,030.30%-307M | 138.37%33M | -177.42%-86M | -3,000.00%-31M | -200.00%-1M | --1M | --0 |
-Other non-cash items | 68.70%636M | 177.25%377M | -597.14%-488M | 48.15%-70M | -200.00%-135M | -116.67%-45M | 27.96%270M | -47.51%211M | 170.16%402M | -174.51%-573M |
Changes in working capital | 62.96%-213M | 39.35%-575M | -410.82%-948M | 7.02%305M | 139.75%285M | -124.47%-717M | 312.01%2.93B | -201.75%-1.38B | -424.82%-458M | 146.23%141M |
-Change in receivables | -167.87%-4.88B | -125.09%-1.82B | -178.70%-809M | -83.91%1.03B | 1,879.67%6.39B | 91.94%-359M | -355.83%-4.45B | 186.44%1.74B | -186.11%-2.01B | 247.01%2.34B |
-Change in inventory | -51.61%-611M | 59.17%-403M | -433.45%-987M | -8.64%296M | 285.14%324M | 32.69%-175M | -46.07%-260M | -709.09%-178M | 80.18%-22M | -50.00%-111M |
-Change in prepaid assets | 407.58%203M | -114.93%-66M | 231.16%442M | -125.67%-337M | 327.95%1.31B | -966.67%-576M | ---54M | ---- | ---- | ---- |
-Change in payables | 206.42%4.68B | 435.44%1.53B | 175.60%285M | 94.16%-377M | -19,085.29%-6.46B | -99.56%34M | 351.96%7.67B | -304.50%-3.04B | 170.42%1.49B | -267.57%-2.11B |
-Provision for loans, leases and other losses | 625.00%105M | -130.30%-20M | 210.00%66M | -2,100.00%-60M | -95.65%3M | 256.82%69M | -728.57%-44M | 122.58%7M | 80.75%-31M | -770.83%-161M |
-Changes in other current assets | 39.71%292M | 280.00%209M | 122.45%55M | 80.99%-245M | -544.48%-1.29B | 286.67%290M | -17.58%75M | -24.79%91M | -35.29%121M | 149.33%187M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 6.52%-43M | 8.00%-46M | 25.37%-50M | 5.63%-67M | -5.97%-71M | 27.17%-67M | 18.58%-92M | -0.89%-113M | -0.90%-112M | 23.97%-111M |
Interest received (cash flow from operating activities) | 6.74%95M | 17.11%89M | 13.43%76M | -10.67%67M | 15.38%75M | 8.33%65M | -18.92%60M | 32.14%74M | 7.69%56M | 10.64%52M |
Tax refund paid | -14.95%-961M | -19.26%-836M | -10.92%-701M | 28.43%-632M | 4.95%-883M | -41.83%-929M | -86.08%-655M | 63.06%-352M | 22.58%-953M | -73.62%-1.23B |
Other operating cash inflow (outflow) | 8.82%-31M | 0.00%-34M | -25.93%-34M | 20.59%-27M | 5.56%-34M | -5.88%-36M | -288.89%-34M | 121.43%18M | -111.46%-84M | 733M |
Operating cash flow | 29.79%3.16B | 198.65%2.43B | -60.80%815M | -7.23%2.08B | 68.50%2.24B | -76.12%1.33B | 515.47%5.57B | -11.27%905M | -45.37%1.02B | -27.27%1.87B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 237.56%553M | -64.08%-402M | -143.91%-245M | 212.50%558M | -15.89%-496M | -38.96%-428M | -596.77%-308M | 118.02%62M | 15.69%-344M | -168.42%-408M |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | 133.33%98M | --42M | ---- | ---- | ---- |
Net investment product transactions | 0.00%-3M | 25.00%-3M | -121.05%-4M | 119.19%19M | -1,337.50%-99M | -65.22%8M | 35.29%23M | 141.46%17M | 59.00%-41M | 41.86%-100M |
Advance cash and loans provided to other parties | 33.33%-6M | 35.71%-9M | -250.00%-14M | 20.00%-4M | 28.57%-5M | 87.50%-7M | -600.00%-56M | 38.46%-8M | -30.00%-13M | -11.11%-10M |
Repayment of advance payments to other parties and cash income from loans | 14.29%8M | -12.50%7M | 33.33%8M | -33.33%6M | -30.77%9M | -78.33%13M | 361.54%60M | 62.50%13M | 14.29%8M | -22.22%7M |
Net changes in other investments | -2,521.05%-498M | -147.50%-19M | 172.73%40M | -292.86%-55M | -227.27%-14M | 116.67%11M | -214.29%-66M | -200.00%-21M | 90.41%-7M | -143.33%-73M |
Investing cash flow | 112.68%54M | -98.14%-426M | -141.03%-215M | 186.61%524M | -98.36%-605M | 0.00%-305M | -584.13%-305M | 115.87%63M | 32.02%-397M | -64.97%-584M |
Financing cash flow | ||||||||||
Net issuance payments of debt | -269.03%-382M | 171.75%226M | 32.98%-315M | -230.99%-470M | 69.66%-142M | 73.01%-468M | -141.50%-1.73B | -375.50%-718M | 89.17%-151M | -49.09%-1.39B |
Net common stock issuance | 2.70%38M | -2.63%37M | 105.11%38M | -2,753.57%-743M | -9.68%28M | 34.78%31M | -23.33%23M | 139.47%30M | -480.00%-76M | 5.26%20M |
Cash dividends paid | -16.10%-375M | -8.39%-323M | 5.40%-298M | -9.00%-315M | -10.31%-289M | -11.49%-262M | -12.98%-235M | -13.04%-208M | -0.55%-184M | -40.77%-183M |
Cash dividends for minorities | 0.00%-5M | -25.00%-5M | 0.00%-4M | 20.00%-4M | -25.00%-5M | 0.00%-4M | 0.00%-4M | 0.00%-4M | 0.00%-4M | 0.00%-4M |
Net other fund-raising expenses | -5.12%-226M | -2.87%-215M | 16.06%-209M | -9.21%-249M | -10.68%-228M | -7.85%-206M | 4.98%-191M | -16.86%-201M | -8.18%-172M | 9.66%-159M |
Financing cash flow | -239.29%-950M | 64.47%-280M | 55.76%-788M | -180.03%-1.78B | 30.03%-636M | 57.54%-909M | -94.46%-2.14B | -87.56%-1.1B | 65.87%-587M | -40.29%-1.72B |
Net cash flow | ||||||||||
Beginning cash position | 15.65%12.78B | -1.66%11.05B | 7.89%11.24B | 10.61%10.42B | 1.25%9.42B | 50.57%9.3B | -2.08%6.18B | 0.56%6.31B | -6.50%6.27B | 17.23%6.71B |
Current changes in cash | 30.96%2.26B | 1,019.15%1.73B | -122.87%-188M | -17.80%822M | 762.07%1B | -96.29%116M | 2,448.87%3.12B | -469.44%-133M | 108.24%36M | -144.28%-437M |
Effect of exchange rate changes | 100.00%2M | 0.00%1M | --1M | --0 | --0 | --0 | --0 | --0 | --0 | --1M |
Cash adjustments other than cash changes | 0.00%1M | --1M | ---- | ---- | ---1M | ---- | ---- | 300.00%2M | ---1M | ---- |
End cash Position | 17.73%15.05B | 15.65%12.78B | -1.66%11.05B | 7.89%11.24B | 10.61%10.42B | 1.25%9.42B | 50.57%9.3B | -2.08%6.18B | 0.56%6.31B | -6.50%6.27B |
Free cash flow | 37.67%2.79B | 255.54%2.02B | -65.83%569M | -3.65%1.67B | 93.51%1.73B | -83.01%893M | 711.11%5.26B | -3.71%648M | -53.00%673M | -39.55%1.43B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |